Posts tagged “Quintiles”
In observance of Feb. 4 as "World Cancer Day," Terry Murdock, the head of the Oncology Center of Excellence at Quintiles, writes in a blog that "there is much to celebrate" this year in the fight against cancer.
With "apathetic" attitudes helping drive down life science industry stocks as part of a general market spiral, Quintiles CEO Tom Pike took to the airways Wednesday evening to defend his company and the biotech-related sector.
As digital health becomes more common in these days of emerging electronic medical records, wearable health devices and more, Quintiles is joining the growing number of companies seeking to capitalize on the world's biggest tech show: CES in Las Vegas. And Durham-based Validic exec will be leading the discussion in which Quintiles is participating.
Quintiles Transactional Holdings (NYSE:Q) reported third quarter earnings of $117.58 million or 94 cents a share, beating analyst expectations of 81 cents a share and a 44.6 percent increase compared to the same period last year.
Quintiles has named Kevin Gordon, currently serving as executive vice president, Operations and chief financial officer (CFO), has been promoted to chief operating officer (COO). The company also said Michael McDonnell is expected to join Quintiles in December 2015 as executive vice president, chief financial officer (CFO).
Quintiles has been named the market leader in Phase IV services for the third year in a row. That's according to the 2015 CRO Quality Benchmarking - Phase IV Service Providers Report from Industry Standard Research (ISR).
In today's Bulldog update of technology news: NC economic development package passes; 3 NC universities on most innovative list; Quintiles plans for Alzheimer's Day Monday; health IT startup to expand.
14M PCs run Windows 10; SciQuest profitable; Quintiles investors selling $500M in shares; Google's 'no' to right-to-be-forgotten; LinkedIn tumbles
In today's wrapup of technology and life science news: Microsoft says 14 million computers are running Windows 10; SciQuest turns a profit; Quintiles investors are selling $500 million in shares; Google says "no" to right-to-be-forgotten in France; and LinkedIn shares tumble despite good quarterly results.
Q2 Solutions, the new life science services subsidiary launched by Quintiles and Quest Diagnostics, has a familiar face leading it as CEO: Costa Panagos, who has worked at Quintiles for the past 15 years. So why give up corporate security to take the new job? How does he feel about it? And what does Q2 offer in terms of improving healthcare? WTW Insiders get the exclusive details.
Quintiles' new joint venture with Quest formally launched Thursday with a work force of some 2,000 people. But will there be layoffs due to any overlap in job functions? Might there also be new jobs created? Let's take a look.
Q2 Solutions, or "Q Squared Solutions," is formally launching today as a new clinical trials laboratory company owned by Quintiles and Quest Diagnostics. The new venture is led by a former Quintiles executive. The new company kicks off with 2,000 employees.